Beta
77433

Success Rate of Left Varicocele Embolization in Management Recurrent Varicocele after Surgery

Article

Last updated: 22 Jan 2023

Subjects

-

Tags

-

Abstract

Abstract Background: Varicoceles dilation of veins are present in 15% of men. Varicocele can be asymptomatic or symptomatic. Symptoms include pain and/or infertility. Varicocele recurrence depend mainly on the used technique for repair. The recurrence rate ranges from 1.05-14.97%. Aim of Study: The purpose of this study is to measure the success rate of the embolization technique in patients with recurrent left symptomatic varicocele after surgery. Patients and Methods: This cross sectional study included 15 patients with symptomatic (pain or infertility) recurrent left varicocele after surgery. Embolization was done at Ain Shams University hospitals from October 2017 to December 2018. Results: Varicocele embolization for recurrent varicocele after surgery has technical success of 93.3%. Conclusion: Embolization is an effective way to treat recurrent varicocele after surgery.

DOI

10.21608/mjcu.2019.77433

Keywords

Varicocele (VC) – Gonadal Vein (GV) – Butyl Cyanoacrylate (BC) – Primary Infertility (PI) – Percutaneous Embolization (PE)

Authors

First Name

HAYTHAM MOHAMED NASSER, M.D.;

Last Name

HATEM SAYED, M.D.

MiddleName

-

Affiliation

The Departments of Radiology* and General Surgery**, Faculty of Medicine, Ain Shams University

Email

-

City

-

Orcid

-

Volume

87

Article Issue

December

Related Issue

11480

Issue Date

2019-12-01

Receive Date

2019-03-15

Publish Date

2019-12-01

Page Start

4,291

Page End

4,295

Print ISSN

0045-3803

Online ISSN

2536-9806

Link

https://mjcu.journals.ekb.eg/article_77433.html

Detail API

https://mjcu.journals.ekb.eg/service?article_code=77433

Order

36

Type

Original Article

Type Code

263

Publication Type

Journal

Publication Title

The Medical Journal of Cairo University

Publication Link

https://mjcu.journals.ekb.eg/

MainTitle

-

Details

Type

Article

Created At

22 Jan 2023